5Brent M. Egan,Yumin Zhao, R. Neal Axon. US Trends in Prevalence, Awareness,Treatment, and Control of Hypertension, 1988-2008 [ J]. the Journal of the Merican Medical Association. 2010,303 (20) :2043- 2050.
6Carlos M. Ferrario, John M. Flack, John E. Strobeck, et al. Individualizing hypertension treatment with impedance cardiography : a meta-analysis of published trials [ J]. the Therapeutic Advances in Cardiovascular Disease. 2010,4( 1 ) :5-16.
7Nitesh Sood, Kurt M. Reinhart, William L. Baker. Combination therapy for the management of hypertension: A review of the evidence [J]. the American Journal of Health-System Pharmacy. 2010,67 ( 11 ) : 885 -894.
8Julius S, K jeldsen SE, Weber M, et al. Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine [ J]. the VALUE randomised trial. 2004,363 : 2022-2031.
9Muller MM. Marker Of endothelial dysfunction clin chem Lab Med,2000,38 (2) :77-85.
